Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0215
Frequently Asked Questions (FAQ's):
What does the Leber Congenital Amaurosis Gene Panel include at Metropolis Healthcare?
It evaluates key retinal and photoreceptor-related genes using high-precision next-generation sequencing.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences targeted genes to identify mutations linked to LCA.
Who should consider taking this test at Metropolis Healthcare?
Infants or children with severe visual impairment, nystagmus, or a family history of early-onset retinal disease may benefit from this panel.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is sufficient for high-quality genetic analysis.
How long does Metropolis Healthcare take to provide the results?
Reports are shared within a standard genetic testing timeframe after detailed sequencing and expert review.
Why choose Metropolis Healthcare for LCA testing?
Metropolis Healthcare offers broad gene coverage, accurate mutation detection, and clinically meaningful interpretation.
Does Metropolis Healthcare provide post-test support?
Yes, expert insights accompany the report to assist clinicians in diagnosis, therapy planning, and family counseling.
Is this test suitable for infants at Metropolis Healthcare?
Yes, the panel is appropriate for newborns, infants, and older patients with suspected Leber congenital amaurosis